CVS Health Files 8-K

Ticker: CVS · Form: 8-K · Filed: 2024-12-05T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, disclosure, corporate-event

Related Tickers: CVS

TL;DR

CVS filed an 8-K on 12/5 for an event on 12/3. Details TBD.

AI Summary

CVS Health Corporation filed an 8-K on December 5, 2024, reporting an event that occurred on December 3, 2024. The filing is categorized under 'Other Events' and 'Financial Statements and Exhibits'. Specific details regarding the nature of the event or any financial implications are not provided in this excerpt.

Why It Matters

This filing indicates a material event has occurred for CVS Health, requiring public disclosure. Investors should look for subsequent filings or press releases for details.

Risk Assessment

Risk Level: low — The filing itself is a standard disclosure and does not inherently present a risk, but the underlying event it reports could have implications.

Key Numbers

Key Players & Entities

FAQ

What specific event is being reported under 'Other Events'?

The provided excerpt does not specify the nature of the 'Other Events' being reported.

When did the earliest reported event occur?

The earliest reported event occurred on December 3, 2024.

What is the filing date of this 8-K report?

This 8-K report was filed on December 5, 2024.

What is the principal executive office address for CVS Health?

The principal executive office is located at One CVS Drive, Woonsocket, Rhode Island 02895.

What is the SEC file number for CVS Health?

The SEC file number for CVS Health is 001-01011.

From the Filing

0001193125-24-270867.txt : 20241205 0001193125-24-270867.hdr.sgml : 20241205 20241204185301 ACCESSION NUMBER: 0001193125-24-270867 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20241203 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241205 DATE AS OF CHANGE: 20241204 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 241527386 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 8-K 1 d910747d8k.htm 8-K 8-K CVS HEALTH Corp false 0000064803 0000064803 2024-12-03 2024-12-03     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 3, 2024       CVS HEALTH CORPORATION (Exact name of registrant as specified in its charter)       Delaware   001-01011   05-0494040 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   One CVS Drive , Woonsocket , Rhode Island   02895 (Address of principal executive offices)   (Zip Code) Registrant’s telephone number, including area code: (401) 765-1500 Former name or former address, if changed since last report: N/A     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.01 per share   CVS   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐        If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Section 8 - Other Events   Item 8.01 Other Events. On December 3, 2024, CVS Health Corporation, a Delaware corporation (the “Company”), entered into an Underwriting Agreement (the “Underwriting Agreement”) with Barclays Capital Inc., Citigroup Global Markets Inc. and Goldman Sachs & Co. LLC, as representatives of the several underwriters named in Sche

View on Read The Filing